Platinum pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via DUB inhibition-dependent caspase activation and Bcr-Abl downregulation

Chronic myelogenous leukemia (CML) is characterized by the chimeric tyrosine kinase Bcr-Abl. T315I Bcr-Abl is the most notorious point mutation to elicit acquired resistance to imatinib (IM), leading to poor prognosis. Therefore, it is urgent to search for additional approaches and targeting strateg...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Xiaoying, Zhao, Chong, Chen, Xin, Zhang, Peiquan, Zang, Dan, Wu, Jinjie, Chen, Jinghong, Long, Huidan, Yang, Li, Huang, Hongbiao, Wang, Xuejun, Shi, Xianping, Liu, Jinbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550844/
https://www.ncbi.nlm.nih.gov/pubmed/28682311
http://dx.doi.org/10.1038/cddis.2017.284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550844/
https://www.ncbi.nlm.nih.gov/pubmed/28682311
http://dx.doi.org/10.1038/cddis.2017.284

Ejemplares similares